Summit Partners Public Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-26,000
Closed -$8.13M 96
2015
Q4
$8.13M Buy
26,000
+9,000
+53% +$2.68M 2.11% 15
2015
Q3
$4.62M Sell
17,000
-23,000
-58% -$7.06M 1.75% 21
2015
Q2
$12.1M Buy
+40,000
New +$11.9M 4.24% 5

Other funds holding AGN

Summit Partners Public Asset Management's AGN Position: Q1 2016 in Review

Summit Partners Public Asset Management sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 26,000 shares — an estimated $8.13M sold.

Summit Partners Public Asset Management first reported a position in AGN in Q2 2015 and held it in 3 quarters. The position peaked at $12.1M in Q2 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Summit Partners Public Asset Management reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 26,000 Allergan plc shares in Q1 2016, an estimated $8.13M.
  • Summit Partners Public Asset Management first reported a position in Allergan plc in Q2 2015 and held it in 3 quarters.
  • Summit Partners Public Asset Management's Allergan plc position peaked at $12.1M in Q2 2015.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Summit Partners Public Asset Management's 13F filing for Q1 2016, filed 16 May 2016.